REQUEST A DEMO
Total
USD $0.00
Search more companies

Distrimedicall de Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Distrimedicall de Colombia S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Distrimedicall de Colombia S.A.S. is an enterprise in Colombia, with the main office in Galapa. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on March 03, 2015. There are currently 13 (2023) people employed by Distrimedicall de Colombia S.A.S.. From the latest financial highlights, Distrimedicall de Colombia S.A.S. reported a net sales revenue drop of 14.38% in 2023. Over the same period, its total assets grew by 30.01%. In 2023, Distrimedicall de Colombia S.A.S.’s net profit margin increased by 0.55%.

Headquarters
Zona Franca Zofia Lote 32 - 2 Bodega 1
Galapa; Atlantico;

Contact Details: Purchase the Distrimedicall de Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Distrimedicall de Colombia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Distrimedicall de Colombia S.A.S. report to view the information.
Incorporation Date:
March 03, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Distrimedicall de Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-14.38%
Total operating revenue
-14.38%
Operating profit (EBIT)
8.7%
Net Profit (Loss) for the Period
8.7%
Total assets
30.01%
Total equity
9.54%
Operating Profit Margin (ROS)
0.55%
Net Profit Margin
0.55%
Return on Equity (ROE)
-0.07%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?